US Patent 7585676 Retroviral vector
Patent 7585676 was granted and assigned to Oxford Biomedica (UK) Limited on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+194 characters)
Article
Patent abstract
Provided herein is a retroviral vector comprising, and capable of expressing, a nucleotide of interest (NOI), wherein the NOI encodes an RNA or protein which is harmful to a cell.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07585676 Retroviral vector US Patent 7585676 Retroviral vector
Infobox
Patent Number
0758567600
Patent Number
758567600
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075856760
Date of Patent
September 8, 2009
0Patent Application Number
120213430
Date Filed
January 29, 2008
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075856760
Date of Patent
September 8, 2009
0Patent Application Number
120213430
Date Filed
January 29, 2008
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07585676 Retroviral vector
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07585676
Date of patent
September 8, 2009
Patent application number
12021343
Date Filed
January 29, 2008
Patent primary examiner
Find more entities like US Patent 7585676 Retroviral vector
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.